Press release
Creative Biolabs Accelerates Antisense Oligonucleotide Innovation Amid Breakthroughs in RNA-Based Therapies
Accelerating the development of antisense oligonucleotide (ASO) therapy through Creative Biolabs' end-to-end ASO design, synthesis, and conjugation solutions.New York, USA - August 21, 2025 - A seminal paper in Nature Chemistry last month showed how designed ASOs are capable of dismantling disease-causing toxic RNA clumps for conditions like ALS and Huntington's. It's a paradigm shift. They discovered how these RNA clumps form and demonstrated that ASOs can reverse them-opening a new frontier in neurotherapeutics.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
In a year of revolutionary discoveries in RNA biology, it is the privilege of Creative Biolabs to reassert its leadership in the development of antisense oligonucleotide (ASO) therapy through its end-to-end, one-stop-shop ASO design [https://www.creative-biolabs.com/gene-therapy/aso-design-synthesis.htm], synthesis, and conjugation solutions. With recent research casting further insight into the therapeutic potential of ASOs to treat neurodegenerative and orphan genetic diseases, Creative Biolabs takes center stage, enabling researchers and biotechs to accelerate breakthroughs in research.
Creative Biolabs' ASO platform is capable of tackling this frontier. Their one-stop ASO development [https://www.creative-biolabs.com/gene-therapy/one-stop-antisense-oligonucleotide-aso-development.htm] service places the entire process-target gene analysis and sequence design, chemical modification to delivery optimization-in one stop. The customers get a seamless workflow wherein overhead is reduced, timelines are compressed, and technical accuracy is optimized.
"We're committed to making innovation possible," a scientist at Creative Biolabs asserted. "Whether you're searching for a low-abundance mutation or designing a successful therapy, our ASO technologies are ready to serve. We've brought together next-gen algorithms, proprietary screening models, and delivery technologies to meet the evolving demands of RNA medicine."
These ASO design & synthesis products of the company consist of first- and second-generation chemistries such as phosphorothioate backbones and 2'-O-methoxyethyl modifications and gapmer structures to provide improved RNase H activity. These modifications provide stability, reduce immunogenicity, and improve target specificity-all cornerstones of clinical success.
Moreover, Creative Biolabs offers ASO conjugate development [https://www.creative-biolabs.com/gene-therapy/aso-conjugate-development.htm], with delivery systems including GalNAc conjugates to target the liver, peptide and aptamer conjugates to target tissue, and lipid nanoparticles (LNPs) for systemic targeting. These platforms are essential in overcoming the pharmacokinetic barrier of ASO therapeutics.
"Creative Biolabs was a huge help in assisting us to optimize our ASO candidates," a director with a biotech start-up focused on rare disease drugs said. "Their technical know-how and quick turnaround provided us with the comfort level to move forward with our IND filing."
As the ASO market keeps expanding-into individualized therapies for ultra-rare diseases and massive therapies for Alzheimer's and cancer-Creative Biolabs is dedicated to making scientific progress simpler.
Learn more, please visit https://www.creative-biolabs.com/gene-therapy.
About Creative Biolabs
Creative Biolabs is a globally renowned biotech company specializing in novel drug discovery and gene therapy technology. It is a market leader in the nucleic acid therapeutic industry that has become a trusted name as a collaborator with scientists and pharma developers requiring novel technologies in antisense oligonucleotides (ASOs), mRNA medicine, and CRISPR-based platforms.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-accelerates-antisense-oligonucleotide-innovation-amid-breakthroughs-in-rnabased-therapies]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/gene-therapy
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
                     Copy
                  
                 Please set a link in the press area of your homepage to this press release on openPR.  openPR disclaims liability for any content contained in this release. 
    You can edit or delete your press release Creative Biolabs Accelerates Antisense Oligonucleotide Innovation Amid Breakthroughs in RNA-Based Therapies here
News-ID: 4154701 • Views: …
More Releases from Getnews
 
                                            
                                                    Deer Mountain Equipment Boosts Inventory and Rental Capacity to Support Northwes …                                                
                                            
                                        
                                            Image: https://www.globalnewslines.com/uploads/2025/10/1761836540.jpg
Deer Mountain Equipment has updated its yard operations and logistics to better serve contractors, landscapers, and rural property managers across the Inland Northwest. With a focus on dependable machines, clear documentation, and hands-on support, the company aims to make equipment selection and fleet coordination feel straightforward, even when project timelines tighten.
Wide selection for resale and preowned needs
The retail floor now features a refreshed mix of late-model units and fully…  
                                        
                                     
                                            
                                                    ZOCHNET Network Operations Center Expands Reliable Internet Solutions Across Gid …                                                
                                            
                                        
                                            Image: https://www.globalnewslines.com/uploads/2025/10/1761840991.jpg
ZOCHNET Network Operations Center has announced an expansion of its advanced internet infrastructure, further strengthening connectivity for residential and business customers throughout the Giddings area. This development reinforces the company's ongoing commitment to providing dependable, high-speed internet access tailored to meet the growing digital demands of the community.
With consistent growth in local industries, education, and remote work, reliable broadband has become an essential service in Giddings, TX. ZOCHNET Network…  
                                        
                                     
                                            
                                                    BALM The Loving Path to Family Recovery A StepbyStep Guide to Reclaiming Peace a …                                                
                                            
                                        
                                            Beverly Buncher's Breakthrough Program Provides Families with Practical Tools for Lasting Recovery
In BALM: The Loving Path to Family Recovery [https://www.amazon.com/BALM-Loving-Path-Family-Recovery-ebook/dp/B07C452MZ3/ref=], Beverly Buncher, MA, PCC, CBFRLC, CTPC, shares her transformative approach to family recovery. Known as the "Foremost Family Recovery Life Coach in the Nation," Buncher unveils her signature BALM Registered Program, a life-changing method designed to help families struggling with a loved one's Substance Use Disorder (SUD). Through this step-by-step…  
                                        
                                     
                                            
                                                    Future Electronics Supports West Island Community Shares in Latest Charity Initi …                                                
                                            
                                        
                                            Image: https://www.globalnewslines.com/uploads/2025/10/1761837653.jpg
Future Electronics' Build Hope Together foundation recently made a cash donation to West Island Community Shares during the company's Thanksgiving luncheon, strengthening their shared mission to support local organizations that help children and teens in need.
Montreal, Quebec - October 30th, 2025 - Future Electronics, a global leading distributor of electronic components, announced a cash donation to West Island Community Shares as part of its Build Hope Together charitable initiative.…  
                                        
                                    More Releases for ASO
                                                    Global Assortment And Space Optimization (ASO) Market Analysis 2025-2030: Growth …                                                
                                            
                                        
                                            The Assortment And Space Optimization (ASO) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Assortment And Space Optimization (ASO) Market Size Expected to Be by 2034?
The market size of the assortment and space optimization (ASO) sector has seen significant expansion in…  
                                        
                                    
                                                    Antisense Oligonucleotide Drugs(ASO Drugs) Market Key Players, Share and Forecas …                                                
                                            
                                        
                                            " The global antisense oligonucleotide (ASO) drugs market is poised for significant growth, with a projected market value of approximately $4.9 billion in 2024. The market is anticipated to expand to around $11.5 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 8.7% during the forecast period from 2025 to 2034. "
Exactitude Consultancy., Ltd. released a research report titled "Antisense Oligonucleotide Drugs(ASO Drugs) Market". This report covers…  
                                        
                                    
                                                    Antisense Oligonucleotides (ASO) Drug Market is estimated to reach USD 12.3 bill …                                                
                                            
                                        
                                            " The global Antisense Oligonucleotides (ASO) drug market is projected to reach approximately $5.8 billion in 2024, driven by increasing applications in molecular therapeutics and genetic disorders. The market is expected to expand significantly, with a forecasted value of around $12.3 billion by 2034, reflecting robust demand and technological advancements in oligonucleotide therapeutics."
Exactitude Consultancy., Ltd. released a research report titled "Antisense Oligonucleotides (ASO) Drug Market". This report covers the global…  
                                        
                                    
                                                    Antisense Oligonucleotide (ASO) Therapeutics Market Size to Reach USD 7,864.9 Mi …                                                
                                            
                                        
                                            The Antisense Oligonucleotide (ASO) Therapeutics market, valued at USD 2,355.4 million in 2024, is expected to register robust revenue CAGR of 16.2%. 
Request free copy of this report: https://navistratanalytics.com/request-free-sample/1256
June 02, 2025 - The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense Oligonucleotide (ASO) therapeutics market. For instance, the American Lung Association reports that cystic fibrosis affects approximately 40,000 individuals in the…  
                                        
                                    
                                                    Assortment and Space Optimization (ASO) Market Sets the Table for Continued Grow …                                                
                                            
                                        
                                            A Latest intelligence report published by Market Research Forecast with title "Global Assortment and Space Optimization (ASO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Assortment and Space Optimization (ASO) market. This report provides a detailed overview of key factors in the Global Assortment and Space Optimization (ASO) Market and factors such as driver, restraint, past and current trends, regulatory scenarios…  
                                        
                                    
                                                    FDA Releases Draft Guidance on CMC For Individualized ASO Therapies                                                
                                            
                                        
                                            SAE Media Group proudly presents the return of the Oligonucleotide Therapeutics & Delivery Conference on the 21st and 22nd September 2022 in London, UK. The two-day conference will bring you high-quality insights and industry connections on the latest clinical trial candidates and a platform for exchanging ideas for tackling the biggest challenge: DELIVERY.
Personalized medicine continues to be at the cutting edge of healthcare, pharmaceuticals, and biotechnology. For patients afflicted with…  
                                        
                                    